• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名COVID-19患者出现血管病变相关皮肤损害和肝内胆汁淤积同步表现;病例报告

Vasculopathy-related cutaneous lesions and intrahepatic cholestasis as synchronous manifestations in a COVID-19 patient; a case report.

作者信息

Sadeghi Amir, Dooghaie Moghadam Arash, Eslami Pegah, Pirsalehi Ali, Salari Sina, Roshandel Elham

机构信息

Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Assistant Professor of Medical Oncology, Hematology and Bone Marrow Transplantation; Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Gastroenterol Hepatol Bed Bench. 2020 Fall;13(4):400-404.

PMID:33244385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7682960/
Abstract

Today, COVID-19 pneumonia causes global concern. The World Health Organization (WHO) has reported many mortalities from this disease all around the world. Therefore, recognizing new cases of COVID-19 is crucial during this pandemic. Many studies have shown that COVID-19 has a broad spectrum of signs and symptoms, including GI and cutaneous manifestations. Previous studies have reported liver enzyme changes as well as diarrhea as a common GI manifestation of COVID-19. However, there are few reports about COVID-19 synchronous cutaneous and liver involvement. Additionally, there are few reports about intrahepatic cholestasis in COVID-19 patients. In this article, a confirmed case of COVID-19 with vasculopathy-related cutaneous manifestation and liver cholestasis is reported. A 67-year-old Iranian woman was admitted to Taleghani Hospital with epigastric pain, vomiting, anosmia, rising liver enzyme levels, fever, itching, and skin rashes. Skin and liver biopsies were performed during the patient's admission; the results suggested vasculopathy-related cutaneous lesion and liver cholestasis. Plasmapheresis was initiated and all manifestations disappeared after treatment. All atypical presentations, including cutaneous lesions and liver manifestations, should be considered as COVID-19 and evaluated.

摘要

如今,新型冠状病毒肺炎引起了全球关注。世界卫生组织(WHO)已报告全球范围内该疾病导致的众多死亡病例。因此,在此次大流行期间识别新型冠状病毒肺炎的新病例至关重要。许多研究表明,新型冠状病毒肺炎有广泛的体征和症状,包括胃肠道和皮肤表现。先前的研究报告了肝酶变化以及腹泻是新型冠状病毒肺炎常见的胃肠道表现。然而,关于新型冠状病毒肺炎同时累及皮肤和肝脏的报道较少。此外,关于新型冠状病毒肺炎患者肝内胆汁淤积的报道也很少。本文报告了一例确诊的新型冠状病毒肺炎病例,该病例伴有血管病变相关的皮肤表现和肝内胆汁淤积。一名67岁的伊朗女性因上腹部疼痛、呕吐、嗅觉丧失、肝酶水平升高、发热、瘙痒和皮疹入住塔莱哈尼医院。患者住院期间进行了皮肤和肝脏活检;结果提示血管病变相关的皮肤病变和肝内胆汁淤积。开始进行血浆置换,治疗后所有症状均消失。所有非典型表现,包括皮肤病变和肝脏表现,都应考虑为新型冠状病毒肺炎并进行评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/725e/7682960/8546a56c11c1/GHFBB-13-400-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/725e/7682960/82b1f9c41d6c/GHFBB-13-400-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/725e/7682960/8546a56c11c1/GHFBB-13-400-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/725e/7682960/82b1f9c41d6c/GHFBB-13-400-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/725e/7682960/8546a56c11c1/GHFBB-13-400-g002.jpg

相似文献

1
Vasculopathy-related cutaneous lesions and intrahepatic cholestasis as synchronous manifestations in a COVID-19 patient; a case report.一名COVID-19患者出现血管病变相关皮肤损害和肝内胆汁淤积同步表现;病例报告
Gastroenterol Hepatol Bed Bench. 2020 Fall;13(4):400-404.
2
Cutaneous hemorrhagic bullae in a patient with COVID-19: A case report.一名新冠肺炎患者的皮肤出血性大疱:病例报告
Med J Islam Repub Iran. 2021 Feb 1;35:15. doi: 10.47176/mjiri.35.15. eCollection 2021.
3
Acute Urticaria as the First Symptom of COVID-19: A Case Report.以急性荨麻疹为新型冠状病毒肺炎首发症状:一例报告
Cureus. 2021 Dec 29;13(12):e20806. doi: 10.7759/cureus.20806. eCollection 2021 Dec.
4
An atypical presentation of COVID-19: Hidden risk for seniors to misdiagnose.新冠肺炎的非典型表现:老年人误诊的潜在风险。
North Clin Istanb. 2023 Aug 4;10(4):521-523. doi: 10.14744/nci.2022.35336. eCollection 2023.
5
Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic.新冠疫情时代的皮肤血管炎和血管病
Front Med (Lausanne). 2022 Aug 23;9:996288. doi: 10.3389/fmed.2022.996288. eCollection 2022.
6
Cutaneous manifestation during COVID-19 pandemic.新冠疫情期间的皮肤表现。
Pediatr Allergy Immunol. 2020 Nov;31 Suppl 26(Suppl 26):89-91. doi: 10.1111/pai.13384.
7
Coronavirus Disease 2019 (COVID-19) and Ecchymosis: A Case Report.2019冠状病毒病(COVID-19)与瘀斑:一例报告
Cureus. 2022 Mar 19;14(3):e23326. doi: 10.7759/cureus.23326. eCollection 2022 Mar.
8
Potential interactions of SARS-CoV-2 with human cell receptors in the skin: Understanding the enigma for a lower frequency of skin lesions compared to other tissues.新冠病毒(SARS-CoV-2)与皮肤细胞受体的潜在相互作用:为了解与其他组织相比皮肤损伤频率较低的谜团。
Exp Dermatol. 2020 Oct;29(10):936-944. doi: 10.1111/exd.14186.
9
Investigating the spectrum of dermatologic manifestations in COVID-19 infection in severely ill patients: A series of four cases.重症 COVID-19 感染患者皮肤表现谱的研究:四例系列报道
J Cutan Pathol. 2021 Jan;48(1):110-115. doi: 10.1111/cup.13867. Epub 2020 Sep 28.
10
COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract.COVID-19 大流行:胃肠道的病理生理学和表现。
World J Gastroenterol. 2020 Aug 21;26(31):4579-4588. doi: 10.3748/wjg.v26.i31.4579.

引用本文的文献

1
Atypical Presentation of COVID-19 in Older Adults: A Scoping Review.老年人中新冠肺炎的非典型表现:一项范围综述
Port J Public Health. 2023 Oct 27;41(3):198-217. doi: 10.1159/000534250. eCollection 2023 Dec.
2
Post-COVID-19 Cholangiopathy: A Systematic Review.新冠病毒感染后胆管病:一项系统综述
J Clin Exp Hepatol. 2023 May-Jun;13(3):489-499. doi: 10.1016/j.jceh.2022.10.009. Epub 2022 Oct 30.
3
Post-COVID-19 Cholestasis: A Case Series and Review of Literature.新冠后胆汁淤积:病例系列及文献综述

本文引用的文献

1
The Impacts of the COVID-19 Pandemic on Liver Transplant Patients; Time to Change the Priorities.新冠疫情对肝移植患者的影响;是时候改变优先事项了。
Arch Iran Med. 2020 Jul 1;23(7):507-508. doi: 10.34172/aim.2020.50.
2
Symmetric cutaneous vasculitis in COVID-19 pneumonia.新型冠状病毒肺炎中的对称性皮肤血管炎
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e362-e363. doi: 10.1111/jdv.16589. Epub 2020 May 27.
3
Common CT Findings of Novel Coronavirus Disease 2019 (COVID-19): A Case Series.2019年新型冠状病毒病(COVID-19)的常见CT表现:病例系列
J Clin Exp Hepatol. 2022 Nov-Dec;12(6):1580-1590. doi: 10.1016/j.jceh.2022.06.004. Epub 2022 Jun 11.
4
Role of therapeutic plasma exchange in the management of COVID-19-induced cytokine storm syndrome.治疗性血浆置换在 COVID-19 诱导的细胞因子风暴综合征治疗中的作用。
Transfus Apher Sci. 2022 Aug;61(4):103433. doi: 10.1016/j.transci.2022.103433. Epub 2022 Mar 23.
Cureus. 2020 Mar 27;12(3):e7434. doi: 10.7759/cureus.7434.
4
Cutaneous manifestations in COVID-19: Lessons learned from current evidence.新型冠状病毒肺炎的皮肤表现:从当前证据中吸取的教训
J Am Acad Dermatol. 2020 Jul;83(1):e57-e60. doi: 10.1016/j.jaad.2020.04.094. Epub 2020 Apr 24.
5
Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis.《中国 2019 年冠状病毒病(COVID-19)的临床特征:系统评价和荟萃分析》
J Infect. 2020 Jun;80(6):656-665. doi: 10.1016/j.jinf.2020.03.041. Epub 2020 Apr 10.
6
COVID-19 and telemedicine: Immediate action required for maintaining healthcare providers well-being.COVID-19 和远程医疗:为维护医疗服务提供者的健康,需立即采取行动。
J Clin Virol. 2020 May;126:104345. doi: 10.1016/j.jcv.2020.104345. Epub 2020 Apr 4.
7
Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease.2019冠状病毒病肝损伤的特征与机制
J Clin Transl Hepatol. 2020 Mar 28;8(1):13-17. doi: 10.14218/JCTH.2020.00019. Epub 2020 Mar 30.
8
Can COVID-19 present unusual GI symptoms?新型冠状病毒肺炎会出现不寻常的胃肠道症状吗?
J Microbiol Immunol Infect. 2020 Jun;53(3):384-385. doi: 10.1016/j.jmii.2020.03.020. Epub 2020 Mar 21.
9
A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19.一种针对新型冠状病毒的新型治疗方法:支持对暴发性新型冠状病毒肺炎使用治疗性血浆置换的观点。
Crit Care. 2020 Apr 2;24(1):128. doi: 10.1186/s13054-020-2836-4.
10
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.抗炎药物在治疗重症新型冠状病毒病 2019(COVID-19)患者中的应用:来自中国临床免疫学家的观点。
Clin Immunol. 2020 May;214:108393. doi: 10.1016/j.clim.2020.108393. Epub 2020 Mar 25.